{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T19:56:23Z","timestamp":1792871783988,"version":"4.5.0"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s10787-026-02392-2","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T15:50:21Z","timestamp":1788364221000},"page":"6549-6560","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Acitretin shows promising potential in Alzheimer\u2019s disease: retinoid-driven modulation of amyloid processing, neuroinflammation, and translational prospects"],"prefix":"10.1007","volume":"34","author":[{"given":"Varun","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanika","family":"Vashisht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garima","family":"Choudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaishali","family":"Choudhay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vandana","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahendra Singh","family":"Ashawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish","family":"Baldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3692-2774","authenticated-orcid":false,"given":"Shiv Kumar","family":"Kushawaha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,2]]},"reference":[{"issue":"1","key":"2392_CR1","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13195-017-0283-5","volume":"9","author":"PS Aisen","year":"2017","unstructured":"Aisen PS et al (2017) On the path to 2025: understanding the Alzheimer\u2019s disease continuum. Alzheimers Res Ther 9(1):60. https:\/\/doi.org\/10.1186\/s13195-017-0283-5","journal-title":"Alzheimers Res Ther"},{"issue":"11","key":"2392_CR2","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.3390\/antiox12111921","volume":"12","author":"J Almaguer","year":"2023","unstructured":"Almaguer J, Hindle A, Lawrence JJ (2023) The Contribution of Hippocampal All-Trans Retinoic Acid (ATRA) Deficiency to Alzheimer\u2019s Disease: A Narrative Overview of ATRA-Dependent Gene Expression in Post-Mortem Hippocampal Tissue. Antioxidants 12(11):1921. https:\/\/doi.org\/10.3390\/antiox12111921","journal-title":"Antioxidants"},{"key":"2392_CR3","doi-asserted-by":"publisher","unstructured":"Alsharief M (2024) How Do Retinoids Affect Alzheimer\u2019s Disease and Can They Be Novel Drug Candidates? Cureus. https:\/\/doi.org\/10.7759\/cureus.57548","DOI":"10.7759\/cureus.57548"},{"issue":"10","key":"2392_CR4","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1080\/1744666X.2022.2116003","volume":"18","author":"H Bachelez","year":"2022","unstructured":"Bachelez H et al (2022) Generalized pustular psoriasis is a disease distinct from psoriasis vulgaris: evidence and expert opinion. Expert Rev Clin Immunol 18(10):1033\u20131047. https:\/\/doi.org\/10.1080\/1744666X.2022.2116003","journal-title":"Expert Rev Clin Immunol"},{"issue":"11","key":"2392_CR5","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1194\/jlr.r100015-jlr200","volume":"43","author":"JE Balmer","year":"2002","unstructured":"Balmer JE, Blomhoff R (2002) Gene expression regulation by retinoic acid. J Lipid Res 43(11):1773\u20131808. https:\/\/doi.org\/10.1194\/jlr.r100015-jlr200","journal-title":"J Lipid Res"},{"key":"2392_CR6","doi-asserted-by":"publisher","first-page":"1667402","DOI":"10.3389\/fneur.2025.1667402","volume":"16","author":"D Baohua","year":"2025","unstructured":"Baohua D et al (2025) Evaluation of the diagnostic efficacy of core biomarkers in cerebrospinal fluid for Alzheimer\u2019s disease: a systematic review and meta-analysis. Front Neurol 16:1667402. https:\/\/doi.org\/10.3389\/fneur.2025.1667402","journal-title":"Front Neurol"},{"issue":"9","key":"2392_CR7","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMoa1202753","volume":"367","author":"RJ Bateman","year":"2012","unstructured":"Bateman RJ et al (2012) Clinical and biomarker changes in dominantly inherited Alzheimer\u2019s disease. N Engl J Med 367(9):795\u2013804. https:\/\/doi.org\/10.1056\/NEJMoa1202753","journal-title":"N Engl J Med"},{"key":"2392_CR8","doi-asserted-by":"publisher","first-page":"976799","DOI":"10.3389\/fphar.2022.976799","volume":"13","author":"T Behl","year":"2022","unstructured":"Behl T (2022) Therapeutic insights elaborating the potential of retinoids in Alzheimer\u2019s disease. Front Pharmacol 13:976799. https:\/\/doi.org\/10.3389\/fphar.2022.976799","journal-title":"Front Pharmacol"},{"issue":"6","key":"2392_CR9","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1111\/joim.12816","volume":"284","author":"K Blennow","year":"2018","unstructured":"Blennow K, Zetterberg H (2018) Biomarkers for Alzheimer\u2019s disease: current status and prospects for the future. J Intern Med 284(6):643\u2013663. https:\/\/doi.org\/10.1111\/joim.12816","journal-title":"J Intern Med"},{"issue":"1","key":"2392_CR10","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nrn2038","volume":"8","author":"ML Block","year":"2007","unstructured":"Block ML, Zecca L, Hong JS (2007) Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 8(1):57\u201369. https:\/\/doi.org\/10.1038\/nrn2038","journal-title":"Nat Rev Neurosci"},{"issue":"16","key":"2392_CR11","doi-asserted-by":"publisher","first-page":"4661","DOI":"10.3390\/jcm13164661","volume":"13","author":"A Bougea","year":"2024","unstructured":"Bougea A, Gourzis P (2024) Biomarker-Based Precision Therapy for Alzheimer\u2019s Disease: Multidimensional Evidence Leading a New Breakthrough in Personalized Medicine. J Clin Med 13(16):4661. https:\/\/doi.org\/10.3390\/jcm13164661","journal-title":"J Clin Med"},{"issue":"1","key":"2392_CR12","doi-asserted-by":"publisher","first-page":"18228","DOI":"10.4088\/JCP.10r05993","volume":"72","author":"JD Bremner","year":"2011","unstructured":"Bremner JD, Shearer KD, McCaffery PJ (2011) Retinoic acid and affective disorders: the evidence for an association. J Clin Psychiatry 72(1):18228. https:\/\/doi.org\/10.4088\/JCP.10r05993","journal-title":"J Clin Psychiatry"},{"issue":"7","key":"2392_CR13","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.3390\/molecules29071478","volume":"29","author":"H Chen","year":"2024","unstructured":"Chen H et al (2024) Neuroinflammation of microglial regulation in Alzheimer\u2019s disease: therapeutic approaches. Molecules 29(7):1478. https:\/\/doi.org\/10.3390\/molecules29071478","journal-title":"Molecules"},{"issue":"4","key":"2392_CR14","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/7214","volume":"2","author":"J Corcoran","year":"1999","unstructured":"Corcoran J, Maden M (1999) Nerve growth factor acts via retinoic acid synthesis to stimulate neurite outgrowth. Nat Neurosci 2(4):307\u2013308. https:\/\/doi.org\/10.1038\/7214","journal-title":"Nat Neurosci"},{"issue":"6075","key":"2392_CR15","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1126\/science.1217697","volume":"335","author":"PE Cramer","year":"2012","unstructured":"Cramer PE et al (2012) ApoE-directed therapeutics rapidly clear \u03b2-amyloid and reverse deficits in AD mouse models. Science 335(6075):1503\u20131506. https:\/\/doi.org\/10.1126\/science.1217697","journal-title":"Science"},{"key":"2392_CR16","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.trci.2019.05.008","volume":"5","author":"J Cummings","year":"2019","unstructured":"Cummings J (2019) Alzheimer\u2019s disease drug development pipeline: 2019. Alzheimer\u2019s Dementia: Translational Res Clin Interventions 5:272\u2013293. https:\/\/doi.org\/10.1016\/j.trci.2019.05.008","journal-title":"Alzheimer\u2019s Dementia: Translational Res Clin Interventions"},{"key":"2392_CR17","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.trci.2018.03.009","volume":"4","author":"J Cummings","year":"2018","unstructured":"Cummings J et al (2018) Alzheimer\u2019s disease drug development pipeline: 2018. Alzheimer\u2019s Dementia: Translational Res Clin Interventions 4:195\u2013214. https:\/\/doi.org\/10.1016\/j.trci.2018.03.009. eCollection 2018","journal-title":"Alzheimer\u2019s Dementia: Translational Res Clin Interventions"},{"issue":"6","key":"2392_CR18","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1007\/s10787-021-00889-6","volume":"29","author":"R Dhapola","year":"2021","unstructured":"Dhapola R et al (2021) Recent advances in molecular pathways and therapeutic implications targeting neuroinflammation for Alzheimer\u2019s Disease. Inflammopharmacology 29(6):1669\u20131681. https:\/\/doi.org\/10.1007\/s10787-021-00889-6","journal-title":"Inflammopharmacology"},{"key":"2392_CR19","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3389\/fnagi.2019.00182","volume":"11","author":"GM dos Santos","year":"2019","unstructured":"dos Santos GM et al (2019) The synthetic retinoid acitretin increases IL-6 in the central nervous system of Alzheimer disease model mice and human patients. Front Aging Neurosci 11:182. https:\/\/doi.org\/10.3389\/fnagi.2019.00182","journal-title":"Front Aging Neurosci"},{"issue":"2","key":"2392_CR20","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00401-016-1662-x","volume":"133","author":"E Drummond","year":"2017","unstructured":"Drummond E, Wisniewski T (2017) Alzheimer\u2019s disease: experimental models and reality. Acta Neuropathol 133(2):155\u2013175. https:\/\/doi.org\/10.1007\/s00401-016-1662-x","journal-title":"Acta Neuropathol"},{"issue":"2","key":"2392_CR21","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.jalz.2015.08.003","volume":"12","author":"FH Duits","year":"2016","unstructured":"Duits FH et al (2016) Performance and complications of lumbar puncture in memory clinics: results of the multicenter lumbar puncture feasibility study. Alzheimer\u2019s Dement 12(2):154\u2013163. https:\/\/doi.org\/10.1016\/j.jalz.2015.08.003","journal-title":"Alzheimer\u2019s Dement"},{"issue":"1","key":"2392_CR22","doi-asserted-by":"publisher","first-page":"9613","DOI":"10.1038\/s41598-023-36772-3","volume":"13","author":"EM Elzayat","year":"2023","unstructured":"Elzayat EM et al (2023) Therapeutic potential of stem cells and acitretin on inflammatory signaling pathway-associated genes regulated by miRNAs 146a and 155 in AD-like rats. Sci Rep 13(1):9613. https:\/\/doi.org\/10.1038\/s41598-023-36772-3","journal-title":"Sci Rep"},{"issue":"7","key":"2392_CR23","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1111\/j.1742-4658.2010.07566.x","volume":"277","author":"K Endres","year":"2010","unstructured":"Endres K, Fahrenholz F (2010) Upregulation of the \u03b1-secretase ADAM10\u2013risk or reason for hope? FEBS J 277(7):1585\u20131596. https:\/\/doi.org\/10.1111\/j.1742-4658.2010.07566.x","journal-title":"FEBS J"},{"issue":"21","key":"2392_CR24","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1212\/WNL.0000000000001017","volume":"83","author":"K Endres","year":"2014","unstructured":"Endres K et al (2014) Increased CSF APPs-\u03b1 levels in patients with Alzheimer\u2019s disease treated with acitretin. Urology 83(21):1930\u20131935. https:\/\/doi.org\/10.1212\/WNL.0000000000001017","journal-title":"Urology"},{"issue":"1","key":"2392_CR25","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3390\/biom14010093","volume":"14","author":"G Garcia-Escobar","year":"2024","unstructured":"Garcia-Escobar G et al (2024) Blood biomarkers of Alzheimer\u2019s disease and cognition: a literature review. Biomolecules 14(1):93. https:\/\/doi.org\/10.3390\/biom14010093","journal-title":"Biomolecules"},{"issue":"6","key":"2392_CR26","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.cell.2010.02.016","volume":"140","author":"CK Glass","year":"2010","unstructured":"Glass CK et al (2010) Mechanisms underlying inflammation in neurodegeneration. Cell 140(6):918\u2013934. https:\/\/doi.org\/10.1016\/j.cell.2010.02.016","journal-title":"Cell"},{"issue":"3","key":"2392_CR27","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1002\/jcp.20784","volume":"209","author":"AB Goodman","year":"2006","unstructured":"Goodman AB (2006) Retinoid receptors, transporters, and metabolizers as therapeutic targets in late onset Alzheimer\u2019s disease. J Cell Physiol 209(3):598\u2013603. https:\/\/doi.org\/10.1002\/jcp.20784","journal-title":"J Cell Physiol"},{"issue":"6","key":"2392_CR28","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1046\/j.1365-2133.2000.03883.x","volume":"143","author":"F Gr\u00f8nh\u00f8j Larsen","year":"2000","unstructured":"Gr\u00f8nh\u00f8j Larsen F et al (2000) Acitretin is converted to etretinate only during concomitant alcohol intake. Br J Dermatol 143(6):1164\u20131169. https:\/\/doi.org\/10.1046\/j.1365-2133.2000.03883.x","journal-title":"Br J Dermatol"},{"issue":"5","key":"2392_CR30","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s00401-017-1707-9","volume":"133","author":"T Guo","year":"2017","unstructured":"Guo T, Noble W, Hanger DP (2017) Roles of tau protein in health and disease. Acta Neuropathol 133(5):665\u2013704. https:\/\/doi.org\/10.1007\/s00401-017-1707-9","journal-title":"Acta Neuropathol"},{"issue":"5","key":"2392_CR29","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.3390\/ijms26052059","volume":"26","author":"H Guo","year":"2025","unstructured":"Guo H et al (2025) An update of salivary biomarkers for the diagnosis of Alzheimer\u2019s disease. Int J Mol Sci 26(5):2059. https:\/\/doi.org\/10.3390\/ijms26052059","journal-title":"Int J Mol Sci"},{"issue":"2","key":"2392_CR31","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1080\/13697137.2017.1287866","volume":"20","author":"H Hampel","year":"2017","unstructured":"Hampel H et al (2017) A precision medicine initiative for Alzheimer\u2019s disease: the road ahead to biomarker-guided integrative disease modeling. Climacteric 20(2):107\u2013118. https:\/\/doi.org\/10.1080\/13697137.2017.1287866","journal-title":"Climacteric"},{"issue":"2","key":"2392_CR32","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1083\/jcb.201709069","volume":"217","author":"DV Hansen","year":"2018","unstructured":"Hansen DV, Hanson JE, Sheng M (2018) Microglia in Alzheimer\u2019s disease. J Cell Biol 217(2):459\u2013472. https:\/\/doi.org\/10.1083\/jcb.201709069","journal-title":"J Cell Biol"},{"issue":"4","key":"2392_CR33","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","volume":"14","author":"MT Heneka","year":"2015","unstructured":"Heneka MT et al (2015a) Neuroinflammation in Alzheimer\u2019s disease. Lancet Neurol 14(4):388\u2013405. https:\/\/doi.org\/10.1016\/S1474-4422(15)70016-5","journal-title":"Lancet Neurol"},{"issue":"3","key":"2392_CR34","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/ni.3102","volume":"16","author":"MT Heneka","year":"2015","unstructured":"Heneka MT, Golenbock DT, Latz E (2015b) Innate immunity in Alzheimer\u2019s disease. Nat Immunol 16(3):229\u2013236. https:\/\/doi.org\/10.1038\/ni.3102","journal-title":"Nat Immunol"},{"key":"2392_CR35","doi-asserted-by":"publisher","first-page":"630502","DOI":"10.3389\/fnins.2021.630502","volume":"15","author":"MA Husain","year":"2021","unstructured":"Husain MA, Laurent B, Plourde M (2021) APOE and Alzheimer\u2019s disease: from lipid transport to physiopathology and therapeutics. Front NeuroSci 15:630502. https:\/\/doi.org\/10.3389\/fnins.2021.630502","journal-title":"Front NeuroSci"},{"issue":"4","key":"2392_CR36","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack Jr","year":"2018","unstructured":"Jack CR Jr et al (2018) NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease. Alzheimer\u2019s Dement 14(4):535\u2013562. https:\/\/doi.org\/10.1016\/j.jalz.2018.02.018","journal-title":"Alzheimer\u2019s Dement"},{"issue":"1","key":"2392_CR37","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12964-023-01072-w","volume":"21","author":"MR Khezri","year":"2023","unstructured":"Khezri MR, Mohebalizadeh M, Ghasemnejad-Berenji M (2023) Therapeutic potential of ADAM10 modulation in Alzheimer\u2019s disease: a review of the current evidence. Cell Communication Signal 21(1):60. https:\/\/doi.org\/10.1186\/s12964-023-01072-w","journal-title":"Cell Communication Signal"},{"issue":"6","key":"2392_CR38","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.jalz.2019.03.004","volume":"15","author":"M Kim","year":"2019","unstructured":"Kim M et al (2019) Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer\u2019s Disease biomarker discovery cohort. Alzheimer\u2019s Dement 15(6):817\u2013827. https:\/\/doi.org\/10.1016\/j.jalz.2019.03.004","journal-title":"Alzheimer\u2019s Dement"},{"issue":"17","key":"2392_CR39","doi-asserted-by":"publisher","first-page":"3020","DOI":"10.1038\/emboj.2010.167","volume":"29","author":"PH Kuhn","year":"2010","unstructured":"Kuhn PH et al (2010) ADAM10 is the physiologically relevant, constitutive \u03b1-secretase of the amyloid precursor protein in primary neurons. EMBO J 29(17):3020. https:\/\/doi.org\/10.1038\/emboj.2010.167","journal-title":"EMBO J"},{"issue":"4","key":"2392_CR40","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.pneurobio.2005.03.002","volume":"75","author":"MA Lane","year":"2005","unstructured":"Lane MA, Bailey SJ (2005) Role of retinoid signalling in the adult brain. Prog Neurobiol 75(4):275\u2013293. https:\/\/doi.org\/10.1016\/j.pneurobio.2005.03.002","journal-title":"Prog Neurobiol"},{"issue":"5","key":"2392_CR41","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1002\/j.1552-4604.1991.tb01907.x","volume":"31","author":"FG Larsen","year":"1991","unstructured":"Larsen FG (1991) The pharmacokinetics of acitretin and its 13-cis\u2010metabolite in psoriatic patients. J Clin Pharmacol 31(5):477\u2013483. https:\/\/doi.org\/10.1002\/j.1552-4604.1991.tb01907.x","journal-title":"J Clin Pharmacol"},{"issue":"1","key":"2392_CR42","doi-asserted-by":"publisher","first-page":"15301","DOI":"10.1038\/s41598-021-94706-3","volume":"11","author":"AA Lauer","year":"2021","unstructured":"Lauer AA et al (2021) Shotgun lipidomics of liver and brain tissue of Alzheimer\u2019s disease model mice treated with acitretin. Sci Rep 11(1):15301. https:\/\/doi.org\/10.1038\/s41598-021-94706-3","journal-title":"Sci Rep"},{"issue":"2","key":"2392_CR43","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s12152-023-09522-5","volume":"16","author":"J Lee","year":"2023","unstructured":"Lee J (2023) Mild cognitive impairment in relation to Alzheimer\u2019s disease: an investigation of principles, classifications, ethics, and problems. Neuroethics 16(2):16. https:\/\/doi.org\/10.1007\/s12152-023-09522-5","journal-title":"Neuroethics"},{"issue":"10248","key":"2392_CR44","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S0140-6736(20)30367-6","volume":"396","author":"G Livingston","year":"2020","unstructured":"Livingston G et al (2020) Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet 396(10248):413\u2013446. https:\/\/doi.org\/10.1016\/S0140-6736(20)30367-6","journal-title":"Lancet"},{"issue":"10","key":"2392_CR45","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/nrn2212","volume":"8","author":"M Maden","year":"2007","unstructured":"Maden M (2007) Retinoic acid in the development, regeneration and maintenance of the nervous system. Nat Rev Neurosci 8(10):755\u2013765. https:\/\/doi.org\/10.1038\/nrn2212","journal-title":"Nat Rev Neurosci"},{"key":"2392_CR46","doi-asserted-by":"crossref","unstructured":"Memudu AE, Olukade BA, Alex GS (2024) Neurodegenerative diseases: Alzheimer\u2019s disease. Integr Neuroimaging Comput Neurosci Artif Intell 128\u2013147","DOI":"10.1201\/9781032711102-8"},{"issue":"4","key":"2392_CR47","doi-asserted-by":"publisher","first-page":"327","DOI":"10.2147\/ciia.2006.1.4.327","volume":"1","author":"S Mukherjee","year":"2006","unstructured":"Mukherjee S et al (2006) Retinoids in the treatment of skin aging: an overview of clinical efficacy and safety. Clin Interv Aging 1(4):327\u2013348. https:\/\/doi.org\/10.2147\/ciia.2006.1.4.327","journal-title":"Clin Interv Aging"},{"issue":"2","key":"2392_CR48","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","volume":"7","author":"E Nichols","year":"2022","unstructured":"Nichols E et al (2022) Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health 7(2):e105\u2013e125. https:\/\/doi.org\/10.1016\/S2468-2667(21)00249-8","journal-title":"Lancet Public Health"},{"key":"2392_CR49","doi-asserted-by":"publisher","unstructured":"Obrocki P, Khatun A, Ness D, Senkevich K, Hanrieder J, Capraro F, Ashton NJ (2020) REVIEW Open Access. https:\/\/doi.org\/10.1186\/s13195-020-00586-6","DOI":"10.1186\/s13195-020-00586-6"},{"key":"2392_CR50","first-page":"2021585957","volume":"20242003","author":"MN Olson","year":"2024","unstructured":"Olson MN et al (2024) Development of a high-throughput, quantitative platform using human cerebral organoids to study virus-induced neuroinflammation in Alzheimer\u2019s Disease. bioRxiv 20242003:2021585957","journal-title":"bioRxiv"},{"issue":"2","key":"2392_CR51","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/j.1447-0594.2011.00786.x","volume":"12","author":"K Ono","year":"2012","unstructured":"Ono K, Yamada M (2012) Vitamin A and Alzheimer\u2019s disease. Geriatr Gerontol Int 12(2):180\u2013188. https:\/\/doi.org\/10.1111\/j.1447-0594.2011.00786.x","journal-title":"Geriatr Gerontol Int"},{"issue":"5","key":"2392_CR52","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1111\/j.1365-2133.2010.09755.x","volume":"162","author":"A Ormerod","year":"2010","unstructured":"Ormerod A, Campalani E, Goodfield M (2010) British Association of Dermatologists guidelines on the efficacy and use of acitretin in dermatology. Br J Dermatol 162(5):952\u2013963. https:\/\/doi.org\/10.1111\/j.1365-2133.2010.09755.x","journal-title":"Br J Dermatol"},{"key":"2392_CR53","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3389\/fnagi.2018.00114","volume":"10","author":"BG Perez-Nievas","year":"2018","unstructured":"Perez-Nievas BG, Serrano-Pozo A (2018) Deciphering the astrocyte reaction in Alzheimer\u2019s disease. Front Aging Neurosci 10:114. https:\/\/doi.org\/10.3389\/fnagi.2018.00114","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"2392_CR54","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/ph11010012","volume":"11","author":"R Peron","year":"2018","unstructured":"Peron R et al (2018) Alpha-secretase ADAM10 regulation: insights into Alzheimer\u2019s disease treatment. Pharmaceuticals 11(1):12. https:\/\/doi.org\/10.3390\/ph11010012","journal-title":"Pharmaceuticals"},{"issue":"4","key":"2392_CR55","doi-asserted-by":"publisher","first-page":"T13","DOI":"10.1530\/JME-22-0097","volume":"69","author":"M Petkovich","year":"2022","unstructured":"Petkovich M, Chambon P (2022) Retinoic acid receptors at 35 years. J Mol Endocrinol 69(4):T13\u2013T24. https:\/\/doi.org\/10.1530\/JME-22-0097","journal-title":"J Mol Endocrinol"},{"key":"2392_CR56","doi-asserted-by":"publisher","first-page":"1371135","DOI":"10.3389\/fnmol.2024.1371135","volume":"17","author":"A Piazza","year":"2024","unstructured":"Piazza A, Carlone R, Spencer GE (2024) Non-canonical retinoid signaling in neural development, regeneration and synaptic function. Front Mol Neurosci 17:1371135. https:\/\/doi.org\/10.3389\/fnmol.2024.1371135","journal-title":"Front Mol Neurosci"},{"issue":"4","key":"2392_CR57","doi-asserted-by":"publisher","first-page":"597","DOI":"10.2165\/00003495-199243040-00010","volume":"43","author":"T Pilkington","year":"1992","unstructured":"Pilkington T, Brogden RN (1992) Acitretin: a review of its pharmacology and therapeutic use. Drugs 43(4):597\u2013627. https:\/\/doi.org\/10.2165\/00003495-199243040-00010","journal-title":"Drugs"},{"key":"2392_CR58","unstructured":"Prince M et al (2015) World Alzheimer report 2015. The global impact of dementia: an analysis of prevalence, incidence, cost and trends. Alzheimer\u2019s Disease International"},{"issue":"4","key":"2392_CR59","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1056\/NEJMra0909142","volume":"362","author":"HW Querfurth","year":"2010","unstructured":"Querfurth HW, LaFerla FM (2010) Alzheimer\u2019s Disease. N Engl J Med 362(4):329\u2013344. https:\/\/doi.org\/10.1056\/NEJMra0909142","journal-title":"N Engl J Med"},{"issue":"20","key":"2392_CR60","doi-asserted-by":"publisher","first-page":"12622","DOI":"10.3390\/ijms232012622","volume":"23","author":"B Ramchatesingh","year":"2022","unstructured":"Ramchatesingh B et al (2022) The use of retinoids for the prevention and treatment of skin cancers: an updated review. Int J Mol Sci 23(20):12622. https:\/\/doi.org\/10.3390\/ijms232012622","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2392_CR61","doi-asserted-by":"publisher","first-page":"6649","DOI":"10.1038\/s41598-021-85912-0","volume":"11","author":"JE Rosales","year":"2021","unstructured":"Rosales JE et al (2021) Acitretin reverses early functional network degradation in a mouse model of familial Alzheimer\u2019s disease. Sci Rep 11(1):6649. https:\/\/doi.org\/10.1038\/s41598-021-85912-0","journal-title":"Sci Rep"},{"issue":"1","key":"2392_CR62","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.cell.2009.01.038","volume":"137","author":"K Saijo","year":"2009","unstructured":"Saijo K (2009) A Nurr1\/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from inflammation-induced death. Cell 137(1):47\u201359. https:\/\/doi.org\/10.1016\/j.cell.2009.01.038","journal-title":"Cell"},{"key":"2392_CR64","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/j.1468-3083.2011.03993.x","volume":"25","author":"E Sbidian","year":"2011","unstructured":"Sbidian E (2011) Efficacy and safety of oral retinoids in different psoriasis subtypes: a systematic literature review. J Eur Acad Dermatol Venereol 25:28\u201333. https:\/\/doi.org\/10.1111\/j.1468-3083.2011.03993.x","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"7","key":"2392_CR63","doi-asserted-by":"publisher","first-page":"CD011535","DOI":"10.1002\/14651858.CD011535.pub6","volume":"7","author":"E Sbidian","year":"2023","unstructured":"Sbidian E et al (2023) Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis. Cochrane Database Syst Reviews 7(7):CD011535. https:\/\/doi.org\/10.1002\/14651858.CD011535.pub6","journal-title":"Cochrane Database Syst Reviews"},{"key":"2392_CR65","doi-asserted-by":"publisher","unstructured":"Sch\u00f6ll M et al (2024) Challenges in the practical implementation of blood biomarkers for Alzheimer\u2019s disease. Lancet Healthy Longev 5(10). https:\/\/doi.org\/10.1016\/j.lanhl.2024.07.013","DOI":"10.1016\/j.lanhl.2024.07.013"},{"issue":"4","key":"2392_CR66","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1007\/s12035-021-02709-y","volume":"59","author":"S Sharma","year":"2022","unstructured":"Sharma S et al (2022) Retinoid X receptor: cellular and biochemical roles of nuclear receptor with a focus on neuropathological involvement. Mol Neurobiol 59(4):2027\u20132050. https:\/\/doi.org\/10.1007\/s12035-021-02709-y","journal-title":"Mol Neurobiol"},{"issue":"12","key":"2392_CR67","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.3390\/cells9122660","volume":"9","author":"\u0141 Szyma\u0144ski","year":"2020","unstructured":"Szyma\u0144ski \u0141 et al (2020) Retinoic acid and its derivatives in skin. Cells 9(12):2660. https:\/\/doi.org\/10.3390\/cells9122660","journal-title":"Cells"},{"key":"2392_CR68","doi-asserted-by":"crossref","unstructured":"Tai LM et al (2014) Soluble apoE\/A\u03b2 complex: mechanism and therapeutic target for APOE4-induced AD risk. Mol neurodegeneration 9(1). 210.1186\/1750-1326-9-2","DOI":"10.1186\/1750-1326-9-2"},{"issue":"1","key":"2392_CR69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10753-022-01721-1","volume":"46","author":"S Thakur","year":"2023","unstructured":"Thakur S et al (2023) Neuroinflammation in Alzheimer\u2019s disease: current progress in molecular signaling and therapeutics. Inflammation 46(1):1\u201317. https:\/\/doi.org\/10.1007\/s10753-022-01721-1","journal-title":"Inflammation"},{"issue":"11","key":"2392_CR70","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.2174\/092986707780597961","volume":"14","author":"DS Thameem","year":"2007","unstructured":"Thameem DS, Kaur C, Ling EA (2007) Microglial activation and its implications in the brain diseases. Curr Med Chem 14(11):1189\u20131197. https:\/\/doi.org\/10.2174\/092986707780597961","journal-title":"Curr Med Chem"},{"issue":"6","key":"2392_CR71","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1096\/fj.08-121392","volume":"23","author":"F Tippmann","year":"2009","unstructured":"Tippmann F (2009) Up-regulation of the \u03b1-secretase ADAM10 by retinoic acid receptors and acitretin. FASEB J 23(6):1643\u20131654. https:\/\/doi.org\/10.1096\/fj.08-121392","journal-title":"FASEB J"},{"issue":"8","key":"2392_CR72","doi-asserted-by":"publisher","first-page":"4311","DOI":"10.1007\/s10787-025-01869-w","volume":"33","author":"K Vashisht","year":"2025","unstructured":"Vashisht K, Kumar H, Ankalgi A, Ashawat MS, Rimpi, Kushawaha SK, & Baldi A (2025). Asperuloside as a promising multi-target agent for Alzheimer\u2019s disease: molecular mechanisms and therapeutic perspectives: K. Vashisht et al. Inflammopharmacology, 33(8), 4311-4321. https:\/\/doi.org\/10.1007\/s10787-025-01869-w","journal-title":"Inflammopharmacology"},{"issue":"37","key":"2392_CR74","doi-asserted-by":"publisher","first-page":"22532","DOI":"10.1074\/jbc.M115.662908","volume":"290","author":"R Wang","year":"2015","unstructured":"Wang R (2015) All-trans-retinoic acid reduces BACE1 expression under inflammatory conditions via modulation of nuclear factor \u03baB (NF\u03baB) signaling. J Biol Chem 290(37):22532\u201322542. https:\/\/doi.org\/10.1074\/jbc.M115.662908","journal-title":"J Biol Chem"},{"issue":"6","key":"2392_CR73","doi-asserted-by":"publisher","first-page":"3876","DOI":"10.1002\/alz.13817","volume":"20","author":"J Wang","year":"2024","unstructured":"Wang J et al (2024) Presynaptic density determined by SV2A PET is closely associated with postsynaptic metabotropic glutamate receptor 5 availability and independent of amyloid pathology in early cognitive impairment. Alzheimer\u2019s Dement 20(6):3876\u20133888. https:\/\/doi.org\/10.1002\/alz.13817","journal-title":"Alzheimer\u2019s Dement"},{"issue":"7573","key":"2392_CR75","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/nature14864","volume":"526","author":"M Willem","year":"2015","unstructured":"Willem M et al (2015) \u03b7-Secretase processing of APP inhibits neuronal activity in the hippocampus. Nature 526(7573):443\u2013447. https:\/\/doi.org\/10.1038\/nature14864","journal-title":"Nature"},{"key":"2392_CR76","doi-asserted-by":"publisher","first-page":"117957352090739","DOI":"10.1177\/1179573520907397","volume":"12","author":"KG Yiannopoulou","year":"2020","unstructured":"Yiannopoulou KG, Papageorgiou SG (2020) Current and future treatments in Alzheimer\u2019s disease: an update. J Cent Nerv Syst Disease 12:1179573520907397. https:\/\/doi.org\/10.1177\/1179573520907397","journal-title":"J Cent Nerv Syst Disease"},{"key":"2392_CR77","doi-asserted-by":"publisher","first-page":"1207280","DOI":"10.3389\/fphys.2023.1207280","volume":"14","author":"T Zhang","year":"2023","unstructured":"Zhang T, Luu MD, Dolga AM, Eisel UL, Schmidt M (2023) The old second messenger cAMP teams up with novel cell death mechanisms: potential translational therapeutic benefit for Alzheimer\u2019s disease and Parkinson\u2019s disease. Front Physiol 14:1207280. https:\/\/doi.org\/10.3389\/fphys.2023.1207280","journal-title":"Front Physiol"},{"issue":"1","key":"2392_CR78","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13024-024-00712-0","volume":"19","author":"MZ Zhong","year":"2024","unstructured":"Zhong MZ et al (2024) Updates on mouse models of Alzheimer\u2019s disease. Mol neurodegeneration 19(1):23. https:\/\/doi.org\/10.1186\/s13024-024-00712-0","journal-title":"Mol neurodegeneration"},{"issue":"5\u20136","key":"2392_CR79","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1159\/000053265s","volume":"54","author":"CC Zouboulis","year":"2000","unstructured":"Zouboulis CC (2000) Human skin: an independent peripheral endocrine organ. Horm Res 54(5\u20136):230\u2013242. https:\/\/doi.org\/10.1159\/000053265s","journal-title":"Horm Res"},{"key":"2392_CR80","doi-asserted-by":"publisher","unstructured":"Zouboulis CC, Orfanos CE (2000) Retinoids. Basic Clin Dermatol 18:171\u2013234. https:\/\/doi.org\/10.1016\/j.curtheres.2018.03.003","DOI":"10.1016\/j.curtheres.2018.03.003"},{"key":"2392_CR81","doi-asserted-by":"publisher","unstructured":"Zweegers J et al (2014) Summary of the Dutch S3-guidelines on the treatment of psoriasis 2011. Dermatol Online J. https:\/\/doi.org\/10.5070\/D3203021769","DOI":"10.5070\/D3203021769"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-026-02392-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-026-02392-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-026-02392-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T23:55:21Z","timestamp":1792194921000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-026-02392-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,2]]},"references-count":81,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["2392"],"URL":"https:\/\/doi.org\/10.1007\/s10787-026-02392-2","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,2]]},"assertion":[{"value":"22 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}